Search

everythinglearnresearchcommunity

for

Search:↓

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

Finasteride effectively reduces prostate size and symptoms in most BPH patients.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

Systemic corticosteroids help manage vitiligo by slowing progression and aiding repigmentation.

Improved nutrition quickly healed the patient's skin lesions.

Non-scarring hair loss in lupus patients often responds well to treatment and doesn't lead to scarring.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

New treatments improved blood pressure control in patients with resistant hypertension.

Autoimmune-related phenomena do not affect the progression or characteristics of lichen sclerosus in women.

VPS13C variants are linked to more severe REM sleep disorder and faster progression to Parkinson's disease.

Early diagnosis and treatment of Folliculitis decalvans are crucial, especially in younger patients and those with bacterial infections.

Early diagnosis and treatment can prevent or delay frontal fibrosing alopecia progression in postmenopausal women.

Incidental prostate cancer was found in 4.89% of patients undergoing surgery for benign prostatic hyperplasia.

Scalp tools, tracking progress, targeting scalp inflammation, and avoiding certain hair treatments can improve female hair loss treatment.

Dupilumab for skin problems might reactivate hair loss in some patients.

Dermatoscopy and videodermatoscopy are useful and reliable for tracking treatment progress in various skin conditions.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

Oral minoxidil helps hair regrowth in 80% of alopecia patients, but only 18% see cosmetic improvement.

Hair transplantation has improved with techniques that increase graft survival and patient satisfaction for more natural results.

The Korean study found that twenty-nail dystrophy mainly affects adults, more often women, and has five distinct types with different clinical progressions.

Some improvements in the aesthetics sector have been made, but patient protection is still lacking due to no compulsory register for practitioners and non-prescription dermal fillers.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

DHCer levels in hair could be a biomarker for alopecia progression.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.